Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Visit-to-Visit Variability of Albuminuria and eGFR as Risk Markers for Renal Complications, Cardiovascular Events, and Mortality in Type 1 Diabetes

    Rotbain Curovic, V., Theilade, S., Winther, S. A., Tofte, N., Jorsal, A., Parving, H., Persson, F., Hansen, T. & Rossing, Peter, 2019, In: Journal of the American Society of Nephrology. 30, Kidney Week Edition, 1 p., SA-PO552.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  2. Published

    Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes

    Rotbain Curovic, V., Theilade, S., Winther, S. A., Tofte, N., Tarnow, L., Jorsal, A., Parving, H. H., Persson, F., Hansen, T. W. & Rossing, Peter, 2021, In: Diabetic Medicine. 38, 5, e14459.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: A randomized trial

    Joergensen, C., Tarnow, L., Goetze, Jens P. & Rossing, Peter, 1 Mar 2015, In: Diabetic Medicine. 32, 3, p. 374-381 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study

    Tougaard, N. H., Hansen, T. W. & Rossing, Peter, 2023, In: Journal of Diabetes and its Complications. 37, 10, 6 p., 108611.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?

    Rossing, Peter & Persson, F., 2021, In: Advances in Chronic Kidney Disease. 28, 4, p. 290-297 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria

    Rathcke, C. N., Persson, F., Tarnow, L., Rossing, Peter & drb459, drb459, 2009, In: Diabetes Care. 32, 2, p. 323-328 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial

    Gæde, P., Øllgaard, J. C., Carstensen, Bendix, Rossing, Peter, Lund-Andersen, H., Parving, H. & Pedersen, Oluf Borbye, Nov 2016, In: Diabetologia. 59, 11, p. 2298-2307 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease

    Theilade, S., Rossing, Peter, Eugen-Olsen, J., Jensen, J. S. & Jensen, M. T., Jun 2016, In: European Journal of Endocrinology. 174, 6, p. 745-53 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...47 48 49 50 51 Next

ID: 12937790